Methylprednisolone vs Rituximab
Methylprednisolone vs Rituximab: Overview
This comparison examines the pharmacological differences between Methylprednisolone and Rituximab.
Mechanism of Action
Methylprednisolone: Intermediate-acting synthetic glucocorticoid.
Rituximab: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.
Pharmacokinetics
Half-life: Methylprednisolone — 18-36 hours; Rituximab — 22 days.
Chemical Properties
Molecular Formula: Methylprednisolone — C22H30O5.
Molecular Weight: Methylprednisolone — 374.4710 g/mol.
Type: Methylprednisolone — Small molecule; Rituximab — Antibody.